Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / RGEN - Repligen: A Cure For COVID-19


RGEN - Repligen: A Cure For COVID-19

  • Repligen is a "pick-and-shovel" play in the bioprocessing industry.
  • Repligen heavily invests in single-use products for use in downstream continuous manufacturing processes, which are two of the latest trend in the bioprocessing industry.
  • COVID-19 programs accounted for approximately 14% of revenue during the latest quarter and approximately 55% of revenue growth.
  • Repligen has a lot further upside, in my opinion, and is currently a buy, despite the high valuation.

For further details see:

Repligen: A Cure For COVID-19
Stock Information

Company Name: Repligen Corporation
Stock Symbol: RGEN
Market: NASDAQ
Website: repligen.com

Menu

RGEN RGEN Quote RGEN Short RGEN News RGEN Articles RGEN Message Board
Get RGEN Alerts

News, Short Squeeze, Breakout and More Instantly...